Lucira Health, Inc.

Emeryville, CA · Medtech · Acquired

Instrument-free point-of-care nucleic acid amplification test for Chlamydia trachomatis and Neisseria gonorrhoeae detection with colorimetric readout in <30 minutes

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · lucirahealth.com

Sector: Medtech
Headquarters: Emeryville, CA
Latest Form D: $15M, Aug 2019
Total capital: $27.3M

Federal grants: $12.3M; 12 awards · 2015–2022; Rank in peer group#117 of 538
Private capital raised: $15M; 1 Form D · last Aug 2019; 87 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 13; 7 pending · first 2020; Rank in peer group#49 of 538

Capital timeline

Latest events

Apr 2022Federal grantHealth and Human S · Phase II · Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$983K
Mar 2021Federal grantHealth and Human S · Phase II · Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$991K
Apr 2020Federal grantHealth and Human S · Phase II · Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$3M
Apr 2020Federal grantHealth and Human S · Phase II · Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$999K
Aug 2019Private capital raisedForm D · SEC · 1st filing$15M
Dec 2017Federal grantHealth and Human S · Phase II · Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae$777K
Jul 2017Federal grantHealth and Human S · Phase II · Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnostics$696K

Show 6 earlier federal awards

Jan 2017Federal grantHealth and Human S · Phase II · Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae$1.5M
Jan 2017Federal grantHealth and Human S · Phase II · Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae$717K
Jul 2016Federal grantHealth and Human S · Phase II · Low Cost Instrument free Point of care Platform for Multiplexed Chlamydia Diagnostics$1.4M
Jun 2016Federal grantHealth and Human S · Phase II · Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnostics$708K
Jun 2015Federal grantHealth and Human S · Phase I · Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnos$300K
Jan 2015Federal grantNSF · Phase I · STTR Phase I: Low-Cost Instrument-free Point-of-Care (POC) Platform for Infectious Disease Diagnostics$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

55months

from Lucira Health, Inc.’s first federal award to its first private round.

First federal award · Jan 2015: NSF · $225K
First Form D · Aug 2019: $15M · 1st Form D
Awards before first raise: 8 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#117 · top 22%
Granted patents#49 · top 9%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Debkishore R. MitraResearcherDirectorLinked by 4 patents · $7.8M in grants as PI
John R. WaldeisenResearcherDirectorLinked by $225K in grants as PI
Erik T. EngelsonExecutive Officer, DirectorNamed in SEC Form D filings
Justin T. ButlerDirectorNamed in SEC Form D filings
Steve R. TablakDirectorNamed in SEC Form D filings
Tuff T. YenDirectorNamed in SEC Form D filings

What it has protected

USPTO · 13 granted of 20

Feb 21, 2023GrantedColorimetric Detection of Nucleic Acid AmplificationUSPTOUS 11,584,957
Oct 11, 2022GrantedMultiplexed Biological Assay Device With Electronic ReadoutUSPTOUS 11,465,142
Aug 30, 2022GrantedAssay Device With Lcd DisplayUSPTOUS D,962,470

Show all 20 patent records

Colorimetric Detection of Nucleic Acid AmplificationFeb 21, 2023 · US 11,584,957Granted
Multiplexed Biological Assay Device With Electronic ReadoutOct 11, 2022 · US 11,465,142Granted
Assay Device With Lcd DisplayAug 30, 2022 · US D,962,470Granted
Medical Testing DeviceJun 21, 2022 · US D,955,598Granted
Diagnostic Device With Led DisplayMay 31, 2022 · US D,953,561Granted
Selectively Vented Biological Assay Devices and Associated MethodsApr 5, 2022 · US 11,291,995Granted
Systems and Methods for Performing Biological AssaysSep 21, 2021 · US 11,123,736Granted
Devices and Methods for Biological Assay Sample Preparation and DeliverySep 21, 2021 · US 11,125,661Granted
Image-based Disease Diagnostics Using A Mobile DeviceAug 3, 2021 · US 11,080,848Granted
Test TubeFeb 9, 2021 · US D,910,200Granted
Medical Testing DeviceJan 5, 2021 · US D,907,232Granted
Colorimetric Detection of Nucleic Acid AmplificationJul 28, 2020 · US 10,724,079Granted
Multiplexed Biological Assay Device With Electronic ReadoutFeb 4, 2020 · US 10,549,275Granted
Multiplexed Biological Assay Device With Electronic ReadoutApplication PCTUS2018044044Pending
Streamlined Assay PreparationApplication PCTUS2021049178Pending
Streamlined Assay PreparationApplication 63075086Pending
Bubble-free Liquid Filling Of Fluidic ChambersApplication PCTUS2020020772Pending
Consumer-based Disease DiagnosticsApplication PCTUS2019055365Pending
Bubble-Free Liquid Filling of Fluidic ChambersApplication 62814143Pending
Systems And Methods For Performing Biological Assays Using A Thermally Sealed ValveApplication 63351427Pending

FLEX ORTHOPAEDICS, INC.Similar federal contract value in Medtech · null in contracts
Synchro Motion LLCSimilar federal contract value in Medtech · null in contracts
RHAEOS, INCSimilar federal contract value in Medtech · null in contracts
NeuraMedica Inc.Similar federal contract value in Medtech · null in contracts
BRITESEED, LLCSimilar federal contract value in Medtech · null in contracts
KILELE HEALTH INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.